ARROWHEAD PHARMACEUTICALS, INC.: capex

Value{"amount": 4713000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2025-10-01 – 2026-03-31
Statuscurrent
EntityARROWHEAD PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000879407-26-000047 · Open the official SEC filing →
Retrieved: 2026-08-19T08:45:39.303906+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000879407/capex/2026-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/b9877289-4004-4e83-9de2-d986c9b9b1cd

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies